World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
19729
World Ranking
3382
National Ranking
1563

Overview

Raphael Clynes is affiliated with Columbia University in the United States and focuses primarily on medical research. Their work spans several subfields including oncology, radiology, nuclear medicine and imaging, immunology, genetics, and pathology and forensic medicine.

Their research topics cover a range of areas with particular attention to:

  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Immunotherapy and Biomarkers
  • Biosimilars and Bioanalytical Methods
  • Immunotherapy and Immune Responses
  • Colorectal Cancer Treatments and Studies
  • Prostate Cancer Treatment and Research

Raphael Clynes has contributed to several publications in multiple journals and conference venues. The most frequent venues for their publications are:

  • Regular and Young Investigator Award Abstracts (5 publications)
  • Journal of Clinical Oncology (3 publications)
  • Blood (2 publications)
  • Journal of the American Academy of Dermatology (2 publications)
  • Blood Advances (1 publication)

Some of the recent papers authored by Raphael Clynes include:

  • "A Phase 1 Study of Plamotamab, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma: Recommended Dose Safety/Efficacy Update and Escalation Exposure-Response Analysis" (2022, Blood)
  • "Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia" (2023, Blood Advances)
  • "An open-label study evaluating the efficacy of abatacept in alopecia areata" (2020, Journal of the American Academy of Dermatology)
  • "523 Preliminary clinical experience with XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors" (2021, Regular and Young Investigator Award Abstracts)
  • "A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3)" (2022, Journal of Clinical Oncology)

Frequent co-authors who have collaborated with Raphael Clynes on multiple occasions include:

  • Jitendra Kanodia
  • Mark N. Stein
  • Ying Ding
  • Steve Kye
  • Siwen Hu-Lieskovan

Best Publications

  • Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.

    Raphael A. Clynes;Terri L. Towers;Leonard G. Presta;Jeffrey V. Ravetch

  • FcR γ chain deletion results in pleiotrophic effector cell defects

    Toshiyuki Takai;Min Li;Diana Sylvestre;Raphael Clynes

  • Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition

    Luzhou Xing;Zhenpeng Dai;Ali Jabbari;Jane E Cerise

  • Uncoupling of Immune Complex Formation and Kidney Damage in Autoimmune Glomerulonephritis

    Raphael Clynes;Calin Dumitru;Jeffrey V. Ravetch

  • Fc receptors are required in passive and active immunity to melanoma

    Raphael Clynes;Yoshizumi Takechi;Yoichi Moroi;Alan Houghton

  • Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II

    Bitao Liang;Craig Workman;Janine Lee;Claude Chew

  • Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors.

    Raphael Clynes;Jay S. Maizes;Rodolphe Guinamard;Masao Ono

  • DIVERGENT ROLES FOR FC RECEPTORS AND COMPLEMENT IN VIVO

    Jeffrey V. Ravetch;Raphael A. Clynes

  • Cell Surface Recycling of Internalized Antigen Permits Dendritic Cell Priming of B Cells

    Amy Bergtold;Dharmesh D. Desai;Anamika Gavhane;Raphael Clynes

  • Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation

    Fayyaz S. Sutterwala;Gary J. Noel;Raphael Clynes;David M. Mosser

  • Immune complex-mediated antigen presentation induces tumor immunity

    Khadija Rafiq;Amy Bergtold;Raphael Clynes

  • Cytotoxic antibodies trigger inflammation through Fc receptors

    Raphael Clynes;Jeffrey V. Ravetch

  • Tumor immunity and autoimmunity induced by immunization with homologous DNA.

    Lawrence W. Weber;Wilbur B. Bowne;Jedd D. Wolchok;Roopa Srinivasan

  • Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci

    Regina C. Betz;Lynn Petukhova;Stephan Ripke;Stephan Ripke;Hailiang Huang;Hailiang Huang

  • Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.

    Julian Mackay-Wiggan;Ali Jabbari;Nhan Nguyen;Jane E. Cerise

  • Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice

    Diana Sylvestre;Raphael Clynes;Minga Ma;Henry Warren

  • IRTA1 and IRTA2, Novel Immunoglobulin Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy

    Georgia Hatzivassiliou;Ira Miller;Jun Takizawa;Nallasivam Palanisamy

  • Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

    Ali Jabbari;Zhenpeng Dai;Luzhou Xing;Jane E. Cerise

  • Augmented HER-2-specific immunity during treatment with trastuzumab and chemotherapy

    Clare Taylor;Dawn Hershman;Nina Shah;Nicole Suciu-Foca

  • Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

    Jianda Yuan;Priti S. Hegde;Raphael Clynes;Periklis G. Foukas;Periklis G. Foukas

  • Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1/PD-L1 therapy.

    Paolo Antonio Ascierto;Ignacio Melero;Shailender Bhatia;Petri Bono

  • CD4+ T Cell–mediated Granulomatous Pathology in Schistosomiasis Is Downregulated by a B Cell–dependent Mechanism Requiring Fc Receptor Signaling

    Dragana Jankovic;Allen W. Cheever;Marika C. Kullberg;Thomas A. Wynn

Frequent Co-Authors

Angela M. Christiano
Angela M. Christiano Columbia University
Kevan C. Herold
Kevan C. Herold Yale University
Jeffrey V. Ravetch
Jeffrey V. Ravetch Rockefeller University
Ann Marie Schmidt
Ann Marie Schmidt New York University
Keith L. Knutson
Keith L. Knutson Mayo Clinic
Edith A. Perez
Edith A. Perez Mayo Clinic
David A. Norris
David A. Norris University of Colorado Anschutz Medical Campus
Nicole Suciu-Foca
Nicole Suciu-Foca Columbia University
Karla V. Ballman
Karla V. Ballman Cornell University
Madeleine Duvic
Madeleine Duvic The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can expand career opportunities, especially in specialized nursing roles. Programs such as the easiest online nurse practitioner programs provide accessible pathways for advancing clinical skills without compromising quality education.

Specializing further, mental health-focused options like the best online pmhnp programs offer strong clinical placement rates, ensuring hands-on experience which is vital for psychiatric nurse practitioners. Affordability is also a major consideration, with several affordable pmhnp programs available to reduce financial barriers while maintaining solid training standards.

Understanding the economic prospects post-degree is important too. The dnp salary by state data highlights how Doctor of Nursing Practice graduates can expect competitive salaries, varying by location. This information helps prospective students make informed decisions about where to study and work after completing online degrees related to Immunology and healthcare.

Best Scientists Citing Raphael Clynes

Trending Scientists

Recently Published Articles